A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.

Borkett, Keith M; Riff, Dennis S; Schwartz, Howard I; Winkle, Peter J; Pambianco, Daniel J; Lees, James P; Wilhelm-Ogunbiyi, Karin

Borkett, Keith M; Riff, Dennis S; Schwartz, Howard I; Winkle, Peter J; Pambianco, Daniel J; Lees, James P; Wilhelm-Ogunbiyi, Karin.

Affiliation

Borkett KM; From the *PAION UK Ltd., Cambridge, United Kingdom; Advanced Clinical Research Institute, Anaheim, California; Miami Research Institute, Miami, Florida; §Charlottesville Medical Research, Charlottesville, Virginia; and â¥PAION Deutschland GmbH, Aachen, Germany.

Anesth Analg ; 120(4): 771-80, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25502841

Subject(s)

Benzodiazepines/therapeutic use; Conscious Sedation/methods; Gastroscopy/methods; Midazolam/therapeutic use; Adolescent; Adult; Aged; Anesthesia Recovery Period; Anesthetics, Intravenous/therapeutic use; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Time Factors; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzodiazepines / Midazolam / Conscious Sedation / Gastroscopy Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Anesth Analg Year: 2015 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google